Pfizer Q3 beats views
at Investor's Business Daily - 2 hrs 12 mins ago
The drugmaker's EPS fell 1 penny from last year to 57 cents a share ex items, topping views by 2 cents. Revenue fell 1.7% to $12.36 bil, beating expectations for $12.24 bil, but Pfizer (PFE) saw 9% growth in emerging markets. Pfizer raised its...
PFE: 29.09 (+0.06)
Pfizer (PFE) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - 2 hrs 24 mins ago
The following Pfizer (PFE) conference call took place on October 28, 2014, 10:00 AM ET. This is a transcript of that earnings call:
PFE: 29.09 (+0.06)
Most active New York Stock Exchange-traded stocks
AP - 2 hrs 43 mins ago
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
GE: 25.88 (+0.36), F: 14.16 (+0.34), S: 6.04 (unch), CLV: 10.57 (+1.49), PFE: 29.09 (+0.06), HAL: 53.26 (+0.87), GM: 31.17 (+1.09), CLF: 11.29 (+2.05), BAC: 16.80 (+0.21), TWTR: 43.78 (-4.78), DOW: 47.98 (+1.49), RAD: 5.06 (+0.26)
Final Glance: Pharmaceuticals companies
AP - 2 hrs 43 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 104.79 (+0.72), BAX: 70.32 (+0.47), PFE: 29.09 (+0.06), BMY: 54.20 (+0.67)
S&P 500 Moves Higher for October as Investors Await Federal Reserve Outlook
at The Street - Tue Oct 28, 4:04PM CDT
The S&P 500 Index, fueled by third-quarter corporate earnings and better-than-feared economic data from China and Europe, is now higher for the month of October.
MSG: 72.99 (+7.21), GILD: 113.45 (+0.86), FB: 80.77 (+0.49), PFE: 29.09 (+0.06), DD: 67.95 (+0.07), TWTR: 43.78 (-4.78)
Twitter and Amgen are big market movers
AP - Tue Oct 28, 3:42PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
AMKR: 6.33 (-1.16), KSS: 54.66 (-3.89), MU: 32.61 (+0.31), PFE: 29.09 (+0.06), HAL: 53.26 (+0.87), AMGN: 157.19 (+8.99), NQ: 8.00 (-1.46), RGC: 21.28 (+0.77), MS: 34.36 (+0.40), MSG: 72.99 (+7.21), NVAX: 5.48 (-0.32), CQB: 14.39 (+0.03), SRPT: 15.12 (-0.79), RCPT: 95.76 (+28.02), TWTR: 43.78 (-4.78), PTIE: 2.07 (+0.12)
Is Twitter's Growth Story Over or Is It Just Getting Started?
at The Street - Tue Oct 28, 3:12PM CDT
CNBC's 'Fast Money' trading panel takes a look at whether investors should buy shares of Twitter on the recent pullback.
TSLA: 242.77 (+21.10), KSS: 54.66 (-3.89), HTZ: 22.43 (+1.05), HES: 81.95 (+1.64), FB: 80.77 (+0.49), PFE: 29.09 (+0.06), M: 57.27 (-1.22), BWLD: 151.68 (+17.86), UAL: 52.36 (+0.63), MSG: 72.99 (+7.21), COH: 34.00 (-2.15), MRK: 55.85 (-0.60), EOG: 91.50 (+3.07), AAL: 40.24 (+0.33), GM: 31.17 (+1.09), GOOGL: 558.94 (+9.06), TWTR: 43.78 (-4.78)
Pfizer Q3 Earnings Top Estimates Despite Generic Pressure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 3:10PM CDT
Pfizer's (PFE) third quarter earnings and revenues were better-than-expected despite the presence of generic pressure.
AGN: 182.60 (+0.27), BIIB: 318.03 (-1.95), PFE: 29.09 (+0.06), ABBV: 60.93 (+0.44)
Stock Market Today: Stocks Move Up Sharply on 7-Year High in Consumer Confidence
at The Street - Tue Oct 28, 2:05PM CDT
U.S. stocks are higher heading into the final hour of trading Tuesday, as a seven-year high in consumer confidence bolstered investors’ feelings about the economy ahead of the holiday season.
MSG: 72.99 (+7.21), FB: 80.77 (+0.49), PFE: 29.09 (+0.06), DD: 67.95 (+0.07), TWTR: 43.78 (-4.78)
Midday Glance: Pharmaceuticals companies
AP - Tue Oct 28, 12:25PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 104.79 (+0.72), BAX: 70.32 (+0.47), PFE: 29.09 (+0.06), BMY: 54.20 (+0.67)
Pfizer Beats Earnings, But Lacks Year-over-Year EPS Growth - Stocks in the News
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:17PM CDT
Pfizer (PFE) stock is in focus following its latest EPS report.
AZN: 71.43 (+0.67), PFE: 29.09 (+0.06), AMGN: 157.19 (+8.99)
Stock Market Today: Stocks Rise on Jump in Consumer Confidence
at The Street - Tue Oct 28, 10:36AM CDT
U.S. stocks rise Tuesday after the Conference Board's index of consumer confidence hit a seven-year high as gas prices nationwide plummeted to multi-year lows.
MSG: 72.99 (+7.21), FB: 80.77 (+0.49), PFE: 29.09 (+0.06), DD: 67.95 (+0.07), TWTR: 43.78 (-4.78)
Early Glance: Pharmaceuticals companies
AP - Tue Oct 28, 9:32AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 104.79 (+0.72), BAX: 70.32 (+0.47), PFE: 29.09 (+0.06), BMY: 54.20 (+0.67)
Get Ready for Shift in Fed Policy - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Oct 28, 9:14AM CDT
The Fed genuinely wants to get out of the QE business and start the monetary policy 'normalization' process.
CMI: 144.59 (+9.22), PFE: 29.09 (+0.06), AET: 77.23 (-1.95)
Pfizer (PFE) Stock Climbs In Pre-Market Trading Today Following Earnings Beat
at The Street - Tue Oct 28, 8:27AM CDT
Pfizer (PFE) shares are rising after the company beat analysts third quarter revenue and earnings estimates.
PFE: 29.09 (+0.06)
Time Magazine Warns Against Investing In Certain "Ebola Stocks"
ACCESSWIRE - Tue Oct 28, 8:22AM CDT
LOS ANGELES, CA / ACCESSWIRE / October 28, 2014 / Time Magazine is today warning investors that while developmental stage pharmas like Inovio Pharmaceuticals (NASDAQ:INO , NewLink Genetics Corp. (NASDAQ:NLNK), Tekmira Pharmaceuticals (NASDAQ:TKMR) and Sarepta Therapeutics (NASDAQ:SRPT) have all generated significant interest among stock market investors lately, there are good reasons to shy away from buying into experimental Ebola treatment therapies. But how can this be?
INO: 11.38 (+0.07), MRK: 55.85 (-0.60), PFE: 29.09 (+0.06), SRPT: 15.12 (-0.79), NLNK: 34.90 (-3.02), TKMR: 18.33 (+0.06), GSK: 45.10 (-0.27), NVS: 92.35 (+2.14)
Stock Market Today: Futures Pare Gains as Durable Goods Fall, Home Prices Rise
at The Street - Tue Oct 28, 8:18AM CDT
U.S. stock futures pared gains after durable goods orders for September fell, missing expectations of a rise. A slightly better-than-expected read on nationwide home prices did little to impact markets.
MSG: 72.99 (+7.21), FB: 80.77 (+0.49), PFE: 29.09 (+0.06), DD: 67.95 (+0.07), TWTR: 43.78 (-4.78)
Amgen Beats on Q3 Earnings & Revenues, Ups View Again - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Oct 28, 8:10AM CDT
Amgen (AMGN), which has performed above expectations over the past few quarters, raised its 2014 guidance yet again.
BIIB: 318.03 (-1.95), PFE: 29.09 (+0.06), AMGN: 157.19 (+8.99), NVS: 92.35 (+2.14)